TERT and urinary bladder cancer: These findings strongly align with previous genomic studies and The Cancer Genome Atlas (TCGA) reports, which also document high rates of mutations in cell cycle regulators, chromatin remodeling genes, and TERT promoter alterations in both muscle-invasive and non–muscle-invasive bladder cancers [16,17].